Marketers are projected to have invested nearly $400 billion in US media in 2025, based on estimates from MAGNA and eMarketer. About half of that will go toward finding new customers. Yet, as ...

A new paper published in Osteoporosis International describes the rigorous, user-centered development of "Build Better Bones, ...

IBM Consulting and The Hackett Group, Inc. (NASDAQ: HCKT) are collaborating to help enterprises accelerate and prioritize AI opportunities using Hackett AI XPLR™. By aligning AI potential to real ...

Three-year capital improvement plan delivers upgraded facilities, new wellness building, and expanded outdoor therapy amenities through 2028 ...

Many hospitalized adults could benefit from linkage to dental care. This article describes a planned study to refer inpatients to community dental providers. Objectives: Previous research suggests ...

SCION: Proven in banking and healthcare, slow to spread everywhere else Feature BGP, the Border Gateway Protocol, was not designed to be secure. It was designed to work – to route packets between the ...

One morning in May 2019, a cardiac surgeon stepped into the operating room at Boston Children’s Hospital more prepared than ever before to perform a high-risk procedure to rebuild a child’s heart. The ...

A 2026 informational overview of how Purisaki Deep Cleansing Foot Pads are described in company materials - including the 2-in-1 detoxification and vitamin infusion positioning, ingredient research ...

Dr. Jacqui Lewis, and attorney Alexandra Rizio, have been actively involved in supporting the couple and navigating the legal challenges posed by ICE and the Department of Homeland Security (DHS). The ...

NFRAs inspection found gaps in audit documentation, revenue testing, and risk assessment practices, stressing the need for ...

Background Alcohol use disorder and treatment-resistant depression (TRD) often co-occur, presenting a major clinical challenge with limited effective treatments. However, ketamine produces rapid ...

While many in the biotechnology sector expressed excitement for faster drug approval timelines, some researchers voiced concerns that critical data review could be missed.